• The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in

No 01 2015

Malin Otmani

-

February 27, 2015

Share article on X
Share article on Linkedin

Updated: August 11, 2026, 09:40 am

Published: February 27, 2015

Top stories

Pharma Business – August 18, 2026

Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

Hansa Biopharma has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix (imlifidase), consistent with the indication approved by the Therapeutic Goods Administration (TGA).

In a new job – August 18, 2026

Bio-Works Technologies appoints new CEO

Eva Lindskog succeeds Lone Carlbom, who will return to an operational role after serving as the company’s CEO.

In a new job – August 18, 2026

He is the new CEO of Elicera Therapeutics

Elicera Therapeutics appoints Johan Liwing as new CEO effective September 1, 2026.

Iceland – August 17, 2026

Pedaling through Iceland to advance multiple myeloma research

From August 18-24, 2026, patients, physicians, caregivers, and supporters from around the world will embark on a six-day cycling expedition across Iceland with the purpose of accelerating research into multiple myeloma.

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

Pharma Business - August 18, 2026

Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

Hansa Biopharma has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix (imlifidase), consistent with the indication approved by the Therapeutic Goods Administration (TGA).

In a new job - August 18, 2026

Bio-Works Technologies appoints new CEO

Eva Lindskog succeeds Lone Carlbom, who will return to an operational role after serving as the company’s CEO.

In a new job - August 18, 2026

He is the new CEO of Elicera Therapeutics

Elicera Therapeutics appoints Johan Liwing as new CEO effective September 1, 2026.

Iceland - August 17, 2026

Pedaling through Iceland to advance multiple myeloma research

From August 18-24, 2026, patients, physicians, caregivers, and supporters from around the world will embark on a six-day cycling expedition across Iceland with the purpose of accelerating research into multiple myeloma.

Business article - August 17, 2026

Evaxion expands and refocuses R&D pipeline

Evaxion expands it pipeline of cancer vaccine programs with EVX-05 against the deadly brain cancer glioblastoma.

Clinical Trials - August 17, 2026

Cereno Scientific activates first clinical site in global Phase IIb trial

The first clinical site has been activated in the company’s global Phase IIb EPIMODE trial evaluating lead drug candidate CS1 in pulmonary arterial hypertension (PAH).

Collaboration - August 17, 2026

Nordic research network aims to strengthen our region’s position in advanced microscopy

The network has researchers from Iceland, Norway, Sweden, Finland and Denmark. “It is absolutely crucial that we work together in the Nordic Region, because this is a rapidly developing scientific field, and when we join forces across the Nordic countries, we can compare ourselves with larger countries such as France, Germany and Italy. The Nordic […]

Sign up to our newsletter: Nordic Life Science News!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.